Related Experiment Video
Updated: Aug 15, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Late cardiac tamponade after percutaneous closure of a patent foramen ovale
Thomas Christen1, François Mach, Dominique Didier
1Division of Cardiology, University Hospital, Geneva, Switzerland.
Insights
A patent foramen ovale (PFO) closure device caused late cardiac tamponade in a patient. Device struts eroded the aortic root, leading to hemorrhagic pericardial effusion and highlighting the need for long-term PFO device follow-up.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Patent foramen ovale (PFO) closure is a common procedure for preventing cryptogenic strokes.
- Percutaneous PFO closure devices are generally considered safe, but potential complications require ongoing investigation.
- Long-term outcomes and rare adverse events associated with PFO closure devices need thorough documentation.
Observation:
- A 35-year-old man experienced a transient ischemic attack and subsequently underwent percutaneous PFO closure using a Cardiastar device.
- One year post-procedure, the patient presented with cardiac tamponade secondary to significant hemorrhagic pericardial effusion.
- Transesophageal echocardiography revealed device strut impingement on the aortic root near the transverse pericardial sinus.
Findings:
- Cardiac CT and surgical findings confirmed device strut perforation of the left atrial roof and aortic root.
- The mechanism is hypothesized to be slow erosion of the aortic wall by a device strut, causing pericardial effusion.
- This represents the first reported case of late-onset cardiac tamponade following PFO closure.
Implications:
- This case highlights a rare but serious late complication of PFO closure devices.
- It underscores the critical importance of long-term patient surveillance and echocardiographic monitoring after PFO device implantation.
- Further research into device design and long-term biocompatibility may be warranted to prevent such adverse events.
Abstract:
We report the case of a 35-year-old man who had a transient ischemic cerebral attack and then underwent a percutaneous closure of the patent foramen ovale (PFO) with a Cardiastar device. One year later, the patient developed a cardiac tamponade due to an important hemorrhagic pericardial effusion. Transoesophageal echocardiography showed that one of the struts had impinged on the aortic root in the region adjacent to the transverse pericardial sinus. Therefore, we speculated that the strut had passed through the aortic wall by slow erosion, leading to the pericardial effusion. Cardiac CT and subsequent surgery confirmed the perforation of the left atrial roof and the aortic root by two struts of the device. This is the first reported case of late cardiac tamponade and underscores the importance of long-term follow-up after PFO closure device implantation.

